• Email Us: [email protected]
  • Contact Us: +1 718 874 1545
  • Skip to main content
  • Skip to primary sidebar

Medical Market Report

  • Home
  • All Reports
  • About Us
  • Contact Us

A Drug To Treat Frostbite Is Finally Available

February 24, 2024 by Deborah Bloomfield

The ConversationFrostbite can occur at temperatures just below freezing (-0.55°C), though at such temperatures frostbite is typically mild and no permanent damage will result. But what happens if you live and work somewhere where it gets much colder?

As a Canadian, I am used to seeing news reports during cold snaps warning people to avoid going outdoors due to frostbite being possible “in under a minute”.

Advertisement

Until now, there have been no approved therapies for severe frostbite. But on February 14 2024, the US Food and Drug Administration (FDA) announced that it had approved the very first drug to treat frostbite.

Frostbite is evolution’s response to prolonged or extreme cold, causing blood vessels to constrict and blood flow to slow in the extremities. This keeps blood flowing in the vital organs warm, increasing the chance of surviving in the extreme cold.

The downside is this can result in permanent damage to the fingers, toes and parts of the face, sometimes requiring amputation of the affected body parts. (Frostbite has resulted in some odd traditions, such as the Sourtoe Cocktail in Dawson City where customers drink a cocktail containing an amputated frostbitten toe.)

Repurposed drug

The new drug, called iloprost (brand name Aurlumyn), is repurposed. This means that it was not originally developed to treat frostbite. In this case, it is used to treat high blood pressure within the lungs.

Advertisement

Repurposed drugs have already passed important (and expensive) human safety testing and are therefore much cheaper (about US$40-80 million or £32-64 million) to develop for additional medical issues versus creating a new drug (about US$1-2 billion), making drug repurposing an attractive way to find new treatments.

Many drugs have been tried as potential treatments for severe frostbite. However, iloprost is the first to be put through a clinical trial where patients with severe frostbite were randomly allocated to receive iloprost or not.

The study found that 60 percent of the patients who did not receive iloprost had injuries sufficiently severe to warrant amputation, versus 0 percent of the patients who received iloprost.

While the total number of patients tested in this study was small at 47, the combined facts that there are no other approved pharmaceutical treatments for frostbite and the impressive digit-saving results found in this randomised human trial were sufficient to convince the FDA to approve this repurposed therapy for severe frostbite.

How it works

Iloprost works by expanding the blood vessels (called a vasodilator) of patients and stopping blood clots from forming. As frostbite causes constriction of blood vessels, this suggests one mechanism through which iloprost helps heal frostbitten tissue is by reversing this constriction.

However, whenever blood flow is reintroduced in such tissue, it can paradoxically worsen the injury and cause more damage. This is called “reperfusion injury” and is largely caused by a sudden influx of oxygen causing oxidative stress. Interestingly, iloprost is not only a vasodilator but also reduces oxidative stress, suggesting this dual mechanism of action could help explain its impressive potential as a frostbite treatment.

Frostbite is a common condition in colder parts of the world with one Finnish study finding that 1.1 percent of the Finnish population experiences severe frostbite every year and 12.9 percent suffer from mild frostbite. As the injuries from frostbite can be serious, the approval of a drug that significantly reduces the risk of life-altering amputations of patients’ fingers, toes and noses will certainly be welcome news to many.

However, an unintended consequence may be that the Sourtoe Cocktail Club has a harder time finding new frostbitten toes to add to its collection in the coming years.

Advertisement

Steven R. Hall, Lecturer in Pharmacology, Lancaster University

This article is republished from The Conversation under a Creative Commons license. Read the original article.

Deborah Bloomfield
Deborah Bloomfield

Related posts:

  1. Soccer – FIFA backs down on threat to fine Premier clubs who play South American players
  2. U.S. House passes abortion rights bill, outlook poor in Senate
  3. UBS clients raise $650 million for biggest yet biotech impact fund
  4. We’ve Breached Six Of The Nine “Planetary Boundaries” For Sustaining Human Civilization

Source Link: A Drug To Treat Frostbite Is Finally Available

Filed Under: News

Primary Sidebar

  • IFLScience Investigates The Loch Ness Monster: A Documentary On The Science, The Story, And The Power Of Belief
  • Remarkably Preserved 23-Million-Year-Old “Frosty” Rhino Discovered In Canadian Arctic
  • Want To “Time Travel” Back To Your Childhood? Baby Filter Image Illusion Could Unlock Lost Memories
  • The Sun Is Giving Us A Spooky Grimace Just In Time For Halloween
  • Comet 3I/ATLAS Reaches Perihelion Today – “Alien Spaceship” Hypothesis To Be Tested Once And For All
  • Search For Shackleton’s “Lost” Ship Uncovered 1,000 Dimples On The Antarctic Seafloor – What Are They?
  • Your Banana Smoothie Might Be Kind Of Self-Defeating, Health-Wise
  • What Are Those Zigzags You See In Spiders’ Webs? Study Finds They Could Be A Kind Of Alarm System
  • The Deepest Fish Ever Filmed Was Found 8,336 Meters Below The Surface In A Vast Ocean Trench
  • Supersonic Flight Without The Boom: NASA’s X-59 Experimental Aircraft Takes Flight For First Time
  • The Oldest Ice Ever Recovered Contains Antarctic Air Bubbles From 6 Million Years Ago
  • Freaky “Frankenstein” Worms Can Get Reproduction Wrong And End Up With Two Heads
  • Hedgehog, Lasagna, and Brussels Sprouts: Meet 2025’s Newly Named North Atlantic Right Whales
  • Can You Be Allergic To Other People? Yes, And It Sounds Like The Worst Thing Ever
  • Animals With “Urban Superpowers” Lurk In London’s Underground, And Some Of Them Want To Drink Your Blood
  • This Is The Largest Radio Color Image Of The Milky Way Ever Assembled – And It’s Gorgeous
  • Why We Can’t Stop Watching True Crime: The Psychological Pull And The Ethical Push
  • “Silent, Ongoing Genocide”: World’s 196 Uncontacted Tribes Are Facing Grave Threats To Their Survival
  • Golden Tigers Are Among The Rarest Big Cats In The World, But They Spell Bad News For Tigers
  • Rare 2-Million-Year-Old Infant Facial Fossils Expand What We Know About Prehistoric Human Children
  • Business
  • Health
  • News
  • Science
  • Technology
  • +1 718 874 1545
  • +91 78878 22626
  • [email protected]
Office Address
Prudour Pvt. Ltd. 420 Lexington Avenue Suite 300 New York City, NY 10170.

Powered by Prudour Network

Copyrights © 2025 · Medical Market Report. All Rights Reserved.

Go to mobile version